ConvaTec Overview

  • Year Founded
  • 1978

Year Founded

  • Status
  • Public

  • Employees
  • 10,136


  • Stock Symbol
  • CTEC

Stock Symbol

  • Investments
  • 16

  • Share Price
  • $3.00
  • (As of Friday Closing)

ConvaTec General Information


Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 29% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 17% of consolidated revenue.

Contact Information

Formerly Known As
Bristol-Myers Squibb (ConvaTec)
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Therapeutic Devices
Stock Exchange
Corporate Office
  • 20 Eastbourne Terrace
  • 7th Floor
  • London W2 6LG
  • England, United Kingdom
+44 01244 000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ConvaTec Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.00 $3.09 $0.03 - $3.73 $6.16B 2.05B 6.01M $0.06

ConvaTec Financials Summary

In Thousands,
TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 7,761,733 7,761,733 6,897,074 6,282,737
Revenue 2,142,400 2,142,400 2,072,500 2,038,300
EBITDA 450,300 450,300 334,700 397,300
Net Income 130,300 130,300 62,900 117,600
Total Assets 3,713,700 3,713,700 3,592,000 3,674,000
Total Debt 1,312,400 1,312,400 1,300,200 1,435,100
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ConvaTec Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ConvaTec‘s full profile, request access.

Request a free trial

ConvaTec Comparisons

HQ Location
Total Raised
Post Valuation
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, co
Therapeutic Devices
London, United Kingdom
10,136 As of 2023
000000000 00 00.000


olor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pari
00000000000 0000000
Charlotte, NC
0000 As of 0000
000000000000 000.00


s nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
00000000000 0000000
Warsaw, IN
00000 As of 0000
000000000 00 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ConvaTec Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Joerns Healthcare Formerly PE-Backed Charlotte, NC 0000 000.00 000000000000 000.00
Zimmer Biomet Holdings Corporation Warsaw, IN 00000 00.000 000000000 00 00.000
Boston Scientific Corporation Marlborough, MA 00000 00.00 000000000 00 00.00
Globus Medical Formerly VC-backed Audubon, PA 0000 00000 000000 - 000 00000
Urgo Medical Corporation Sulzbach, Germany 000
You’re viewing 5 of 8 competitors. Get the full list »

ConvaTec Patents

ConvaTec Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4157375-A1 Modified porcine scaffolds and methods of preparation Pending 26-May-2020 000000000
AU-2021281238-A1 Modified porcine scaffolds and methods of preparation Pending 26-May-2020 000000000
CA-3179245-A1 Modified porcine scaffolds and methods of preparation Pending 26-May-2020 000000000
US-20230355840-A1 Modified porcine scaffolds and methods of preparation Pending 26-May-2020 00000000000
EP-4157375-A4 Modified porcine scaffolds and methods of preparation Pending 26-May-2020 A61L15/44 0
To view ConvaTec’s complete patent history, request access »

ConvaTec Executive Team (27)

Name Title Board Seat Contact Info
Karim Bitar Chief Executive Officer & Board Member
Seth Segel President & Chief Operating Officer- Continence Care & Home Services Group
Kjersti Grimsrud President & Chief Operating Officer Infusion Care
Jonny Mason Chief Financial Officer, Finance & Board Member
Divakar Ramakrishnan Ph.D Chief Technology Officer & Head of Research & Development
You’re viewing 5 of 27 executive team members. Get the full list »

ConvaTec Board Members (30)

Name Representing Role Since
00000 000 ConvaTec Board Member, Chairman of Remuneration Committee & Member of Audit & Risk and Nomination Committee 000 0000
00000 000000 Self Board Member 000 0000
0000000 00000 Self Board Member, Member of Audit & Risk Committee and Member of Nomination Committee 000 0000
0000 000000 ConvaTec Chairman & Director 000 0000
00000 00000 ConvaTec Chief Financial Officer, Finance & Board Member 000 0000
You’re viewing 5 of 30 board members. Get the full list »

ConvaTec Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ConvaTec Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ConvaTec‘s full profile, request access.

Request a free trial

ConvaTec Investments & Acquisitions (16)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Starlight Science 18-Apr-2023 0000000000 00000 Other Devices and Supplies
Coloplast (medical adhesives business) 01-Jan-2023 0000000000 00.00 Medical Supplies
BlueWind Medical 04-May-2022 00000 0000 0000 Therapeutic Devices 0000 0000
Triad Life Sciences 24-Feb-2022 0000000000 00000 Biotechnology 00000 000
Patient Care Medical 01-Dec-2021 Merger/Acquisition 000.00 Distributors/Wholesale
You’re viewing 5 of 16 investments and acquisitions. Get the full list »

ConvaTec Subsidiaries (13)

Company Name Industry Location Founded
Triad Life Sciences Biotechnology Memphis, TN 2017
Patient Care Medical Distributors/Wholesale Austin, TX 0000
AbViser Medical Monitoring Equipment Montgomery, NJ 0000
Convatec (Germany) Specialty Retail Munich, Germany 0000
Convatec (Sweden) Distributors/Wholesale Solna, Sweden 0000
You’re viewing 5 of 13 subsidiaries. Get the full list »

ConvaTec ESG

Risk Overview

Risk Rating

Updated June, 01, 2024

14.48 | Low Risk

Risk Scale

A lower score indicates better sustainability












Exposure refers to the extent to which a company is exposed to different material ESG issues



Management is related to actions taken to manage ESG issues


Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.


Covered Companies

00 of 16,191






00 of 643




Medical Supplies


00 of 58




To view ConvaTec’s complete esg history, request access »

ConvaTec Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Trio Healthcare International 01-Jun-2012 0000000000 Completed
  • 3 buyers
To view ConvaTec’s complete exits history, request access »

ConvaTec FAQs

  • When was ConvaTec founded?

    ConvaTec was founded in 1978.

  • Who is the CEO of ConvaTec?

    Karim Bitar is the CEO of ConvaTec.

  • Where is ConvaTec headquartered?

    ConvaTec is headquartered in London, United Kingdom.

  • What is the size of ConvaTec?

    ConvaTec has 10,136 total employees.

  • What industry is ConvaTec in?

    ConvaTec’s primary industry is Therapeutic Devices.

  • Is ConvaTec a private or public company?

    ConvaTec is a Public company.

  • What is ConvaTec’s stock symbol?

    The ticker symbol for ConvaTec is CTEC.

  • What is the current stock price of ConvaTec?

    As of 21-Jun-2024 the stock price of ConvaTec is $3.00.

  • What is the current market cap of ConvaTec?

    The current market capitalization of ConvaTec is $6.16B.

  • What is ConvaTec’s current revenue?

    The trailing twelve month revenue for ConvaTec is $2.14B.

  • Who are ConvaTec’s competitors?

    Joerns Healthcare, Zimmer Biomet Holdings, Boston Scientific, Globus Medical, and Urgo Medical are some of the 8 competitors of ConvaTec.

  • What is ConvaTec’s annual earnings per share (EPS)?

    ConvaTec’s EPS for 12 months was $0.06.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »